In the present research, we have specifically explored the differences in the levels of TLR2 and TLR4 and associated inflammatory markers in primary human cells derived from fresh surgically resected tissue samples of patients with LGGs and HGGs, as well as patients with epilepsy as a nontumor intracranial disease. The gene discussed is TLR2; the disease is epilepsy.